SBC Medical Group Joins Russell 3000 Index and Appoints New CMO Amid Global Expansion
SBC Medical Group's inclusion in the Russell 3000 Index and the appointment of a new Chief Marketing Officer underscore its growing significance in the global cosmetic surgery market.
SBC Medical Group Holdings Inc. (NASDAQ: SBC) has been added to the Russell 3000® Index, marking a significant milestone for the global franchise and provider of aesthetic clinic services. This inclusion, effective as of June 30, 2025, enhances the company's visibility among institutional and individual investors, potentially reducing stock volatility and affirming its economic relevance. The Russell 3000 Index is a benchmark for about $18.1 trillion in assets globally, with $10.6 trillion in the U.S. alone, highlighting the importance of SBC Medical Group's addition to the index.
Separately, the company announced the appointment of Shinya Inoue as its new Chief Marketing Officer (CMO). Inoue, with a background in leading marketing strategies at major corporations like Pioneer Corporation and P&G Japan, is expected to drive the evolution of SBC Medical Group's marketing infrastructure, focusing on digital innovation. His expertise is anticipated to bolster the company's global expansion and brand elevation efforts, particularly for Shonan Beauty Clinic, one of Japan's leading aesthetic medical brands.
The inclusion in the Russell 3000 Index and the strategic appointment of a new CMO reflect SBC Medical Group's robust growth trajectory in the cosmetic surgery market, both in Japan and internationally. With 251 clinics and a reported 71% customer return rate in the first quarter of 2025, alongside a 5% year-over-year increase in earnings per share, the company is well-positioned for continued success in the evolving aesthetic medical industry.